Comparative study of biphasic calcium phosphate with beta-tricalcium phosphate in rat cranial defects-A molecular-biological and histological study

The in vivo biocompatibility of BCP is to a large part identical to those of TCP. Within the limitation of the animal model, the implantation study shows that BCP can be used as bone graft substitute, due to the fact that the material integrates into tissue, remains stable in the implantation bed and serves as an osteoconductive scaffold.